192 related articles for article (PubMed ID: 31678759)
1. First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis.
Alavifard S; Chase R; Janoudi G; Chaumont A; Lanes A; Walker M; Gaudet L
Pregnancy Hypertens; 2019 Oct; 18():179-187. PubMed ID: 31678759
[TBL] [Abstract][Full Text] [Related]
2. Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
Wu HZ; Cheng Y; Yu D; Li JB; Jiang YF; Zhu ZN
Hypertens Pregnancy; 2022 May; 41(2):126-138. PubMed ID: 35361052
[TBL] [Abstract][Full Text] [Related]
3. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis.
Shekhar S; Gupta N; Kirubakaran R; Pareek P
BJOG; 2016 Jan; 123(1):40-7. PubMed ID: 26113232
[TBL] [Abstract][Full Text] [Related]
4. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
[TBL] [Abstract][Full Text] [Related]
5. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
Sridharan K; Sequeira RP
Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
[TBL] [Abstract][Full Text] [Related]
6. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
[TBL] [Abstract][Full Text] [Related]
7. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
[TBL] [Abstract][Full Text] [Related]
8. PP088. Oral antihypertensive therapy for severe hypertension in pregnancy.
Firoz T; Magee LA; Lalani S; Sawchuck D; Payne B; Vidler M; Gordon R; von Dadelszen P;
Pregnancy Hypertens; 2012 Jul; 2(3):288. PubMed ID: 26105410
[TBL] [Abstract][Full Text] [Related]
9. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
Magee LA; Cham C; Waterman EJ; Ohlsson A; von Dadelszen P
BMJ; 2003 Oct; 327(7421):955-60. PubMed ID: 14576246
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of nifedipine versus hydralazine in the management of severe hypertension in pregnancy: A randomised controlled trial.
Adebayo JA; Nwafor JI; Lawani LO; Esike CO; Olaleye AA; Adiele NA
Niger Postgrad Med J; 2020; 27(4):317-324. PubMed ID: 33154284
[TBL] [Abstract][Full Text] [Related]
11. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
Kilpatrick SJ; Abreo A; Greene N; Melsop K; Peterson N; Shields LE; Main EK
Am J Obstet Gynecol; 2016 Jul; 215(1):91.e1-7. PubMed ID: 26829504
[TBL] [Abstract][Full Text] [Related]
12. The flipside of hydralazine in pregnancy: A systematic review and meta-analysis.
Antza C; Dimou C; Doundoulakis I; Akrivos E; Stabouli S; Haidich AB; Goulis DG; Kotsis V
Pregnancy Hypertens; 2020 Jan; 19():177-186. PubMed ID: 32044579
[TBL] [Abstract][Full Text] [Related]
13. Hypertensive emergencies in pregnancy.
Vadhera RB; Simon M
Clin Obstet Gynecol; 2014 Dec; 57(4):797-805. PubMed ID: 25314092
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy and perinatal outcome of nifedipine for severe preeclampsia: meta-analysis].
Liu QQ; Yu YH; Gong SP; Huang LP
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):592-7. PubMed ID: 23141179
[TBL] [Abstract][Full Text] [Related]
15. Postpartum Hypertension: Etiology, Diagnosis, and Management.
Sharma KJ; Kilpatrick SJ
Obstet Gynecol Surv; 2017 Apr; 72(4):248-252. PubMed ID: 28426127
[TBL] [Abstract][Full Text] [Related]
16. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Hussein M; Mooij JM; Roujouleh H
Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
[TBL] [Abstract][Full Text] [Related]
17. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
van de Vusse D; Mian P; Schoenmakers S; Flint RB; Visser W; Allegaert K; Versmissen J
Eur J Clin Pharmacol; 2022 Nov; 78(11):1763-1776. PubMed ID: 36104450
[TBL] [Abstract][Full Text] [Related]
19. IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial.
Zulfeen M; Tatapudi R; Sowjanya R
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():46-52. PubMed ID: 30878897
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with appropriate treatment of acute-onset severe obstetrical hypertension.
Deshmukh US; Lundsberg LS; Culhane JF; Partridge C; Reddy UM; Merriam AA; Son M
Am J Obstet Gynecol; 2021 Sep; 225(3):329.e1-329.e10. PubMed ID: 34023314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
